Yale researchers discover Legionnaire microbe's tricks

Jun 19, 2008

Yale University researchers have shed new light how bacteria like the ones that cause Legionnaires' disease and Q-fever raise such havoc in human patients.

In order to survive, the gram-negative bacteria use genes that have evolved in tandem with ones in their hosts to essentially disarm immune system cells trying to kill them, the scientists report Friday in the journal Science.

"Because of their life style, trying to identify how these organisms cause disease has been really difficult,'' said Craig Roy, professor at the Yale School of Medicine in the section of microbial pathogenesis.
Roy and his group described one innovative way the organisms inflict their damage with impunity.

Some gram-negative pathogens such as Legionella pneumophila, and Coxiella burnetii, the cause of Q fever, actually secrete proteins into eukaryotic cells, or cells with a nucleus. But exactly what those proteins did was not known.

Legionnaires' disease is a dangerous form of pneumonia often contracted by inhaling water droplets containing the organism. Q-fever in humans can cause high fevers, chills and can also develop into pneumonia. Both often go undiagnosed.

Previous genome scans of the gram-negative bacteria that cause these diseases had identified a high prevalence of genes called Anks, for ankyrin repeat homology domains. These genes fascinated scientists because they appear very similar to numerous genes in eukaryotic cells that regulate a multitude of processes. These bacteria have "borrowed'' or co-evolved genes from their hosts to survive in the cell. In fact, some species of these bacteria cannot exist outside of a eukaryotic cell.

Roy's lab showed that Ank proteins are secreted into immune system cells called macrophages, and once inside, turn off mechanisms within the cell designed to destroy the bacteria.

Roy believes that more such survival tricks of gram-negative pathogens will be found but adds, "this study at least gives us a foothold" for further study.

Because these bacteria tend to behave like viruses and actually invade cells, they might be susceptible to a vaccine that targets specific elements of the Ank protein and allow macrophages to complete the job, he said.

Source: Yale University

Explore further: Research milestone in CCHF virus could help identify new treatments

add to favorites email to friend print save as pdf

Related Stories

'Immortal' flatworms may be a weapon against bacteria

Sep 11, 2014

A novel mode of defense against bacteria such as the causal agent of tuberculosis or Staphylococcus aureus has been identified in humans by studying a small, aquatic flatworm, the planarian. This discovery ...

Microalgae – the factories of the future

Sep 09, 2014

Biology professor Ralf Kaldenhoff is making microalgae fit for industry. The microorganisms could produce a variety of products from carbon dioxide and light.

Recommended for you

A new way to prevent the spread of devastating diseases

7 hours ago

For decades, researchers have tried to develop broadly effective vaccines to prevent the spread of illnesses such as HIV, malaria, and tuberculosis. While limited progress has been made along these lines, ...

New molecule allows for increase in stem cell transplants

8 hours ago

Investigators from the Institute for Research in Immunology and Cancer (IRIC) at the Université de Montréal have just published, in the prestigious magazine Science, the announcement of the discovery of a new molecule, the fi ...

Team explores STXBP5 gene and its role in blood clotting

10 hours ago

Two independent groups of researchers led by Sidney (Wally) Whiteheart, PhD, of the University of Kentucky, and Charles Lowenstein, MD, of the University of Rochester, have published important studies exploring the role that ...

User comments : 0